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Proteins containing a caveolin-binding domain (CBD),
such as the Rho-GTPases, can interact with caveolin-1
(Cav1) through its caveolin scaffold domain. Rho-
GTPases are important regulators of p130
Cas, which is
crucial for both normal cell migration and Src kinase-
mediated metastasis of cancer cells. However, although
Rho-GTPases (particularly RhoC) and Cav1 have been
linked to cancer progression and metastasis, the under-
lying molecular mechanisms are largely unknown. To
investigate the function of Cav1–Rho-GTPase interaction
in metastasis, we disrupted Cav1–Rho-GTPase binding
in melanoma and mammary epithelial tumor cells by
overexpressing CBD, and examined the loss-of-function
of RhoC in metastatic cancer cells. Cancer cells over-
expressing CBD or lacking RhoC had reduced p130
Cas
phosphorylation and Rac1 activation, resulting in an
inhibition of migration and invasion in vitro. The activity
of Src and the activation of its downstream targets FAK,
Pyk2, Ras and extracellular signal-regulated kinase
(Erk)1/2 were also impaired. A reduction in a5-integrin
expression, which is required for binding to ﬁbronectin
and thus cell migration and survival, was observed in
CBD-expressing cells and cells lacking RhoC. As a result
of these defects, CBD-expressing melanoma cells had
a reduced ability to metastasize in recipient mice, and
impaired extravasation and survival in secondary sites
in chicken embryos. Our data indicate that interaction
between Cav1 and Rho-GTPases (most likely RhoC but
not RhoA) promotes metastasis by stimulating a5-integrin
expression and regulating the Src-dependent activation
of p130
Cas/Rac1, FAK/Pyk2 and Ras/Erk1/2 signaling
cascades.
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Introduction
The scaffold protein p130
Cas, Rho-GTPases and
caveolin-1 (Cav1) are among the key signaling mole-
cules mediating actin cytoskeleton remodeling (Hall
1998; Meenderink et al., 2010; Fecchi et al., 2011). This
remodeling depends on Rac1 activation, which is
controlled by phosphorylated p130
Cas (Marti et al.,
1997; Ohta et al., 1999; Brabek et al., 2005). Phosphory-
lation of p130
Cas is thus a pivotal step in cell movement
and metastasis. In normal and cancer cells, p130
Cas is
phosphorylated by Src kinase, thus Src also regulates
the cytoskeleton (Sakai et al., 1994). Src-mediated
p130
Cas phosphorylation drives Rac1 activation at the
cell’s leading edge (Timpson et al., 2001; Sharma and
Mayer 2008), thereby promoting cell motility.
Rho-GTPases have been linked to cancer cell migra-
tion/invasion, and elevated levels of RhoC have been
frequently associated with metastasis (Sahai and Marshall
2002; Narumiya et al., 2009). Our previous work showed
that RhoC
þ/ PyMT and RhoC
 / PyMT mice develop
primary tumors at the same frequency but RhoC
 / PyMT
mice exhibit signiﬁcantly fewer metastatic lesions in the
lungs (Hakem et al., 2005). In vitro, mammary tumor cells
from RhoC
 / PyMT animals show greatly impaired
migration/invasion abilities. However, the underlying
mechanism by which RhoC functions in metastasis is
largely unknown. At the molecular level, small Rho-
GTPases are required not only for cytoskeletal remodel-
ing but also for Ras-induced transformation (Yamamoto
et al., 1999; Jaffe and Hall 2002). Ras activates various
downstream mediators important for cell migration,
proliferation and survival (Bonni et al., 1999; Yip et al.,
2007). Rho-GTPases are also linked to integrins, which
are critical for cell adhesion, migration and survival.
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ses the Rho/ROCK pathway, thus blocking cell invasion
and metastasis (Kidera et al., 2010).
The scaffold protein Cav1 appears to act either as
a tumor suppressor or as an oncogene but its precise role
in metastasis remains unclear (Goetz et al., 2008; Quest
et al., 2008). Although Cav1
 /  mice do not develop
spontaneous tumors, these animals did develop malig-
nancies when either treated with a carcinogen (Capozza
et al., 2003) or crossed with a tumor-prone strain such
as the MMTV–PyMT (mouse mammary tumor virus–
polyoma middle-T antigen) mouse (Williams et al., 2003,
2004). On the other hand, the TRAMP mouse model
(transgenic adenocarcinoma of mouse prostate), which
develops spontaneous prostate carcinomas, exhibited
greatly reduced metastatic spread when Cav1 was
genetically deleted (Williams et al.,2 0 0 5 ) .I nt u m o r - p r o n e
mice, loss of Cav1 gene expression dramatically accele-
rated the development of multifocal dysplastic mammary
lesions (Williams et al., 2003). However, increased Cav1
expression correlated with metastasis in later neoplastic
stages during hepatocellular carcinogenesis (Cokakli
et al., 2009). Also, increased Cav1 expression have been
observed in melanoma, lung adenocarcinoma, prostate
cancer and renal cell carcinoma in humans (Thompson
et al., 1999; Li et al.,2 0 0 1 ;H oet al., 2002; Campbell
et al., 2008; Felicetti et al., 2009). These conﬂicting
observations highlight the lack of understanding of the
diverse biological role of Cav1 in cancer.
At the biochemical level, Cav1 co-fractionates with
many signaling molecules, including Rho-GTPases (Smart
et al., 1999; Couet et al., 2001). Rho-GTPases bind to
Cav1 through their caveolin-binding domains (CBDs)
(Couet et al., 1997). In vitro,a ni s o l a t e dC B Dp e p t i d e
derived from a G-protein was shown to interact directly
with the caveolin scaffold domain of Cav1 and compe-
titively inhibits the binding of the G-protein to Cav1
(Couet et al.,1 9 9 7 ) .T h i sm a k e st h eC B Dau s e f u lt o o lf o r
examining the effects of disrupting the Cav1–Rho-GTPase
interaction on cell migration, invasion and metastasis.
In this study, we show that the disruption of Cav1–
Rho-GTPase interaction prevents the activation of Rac1
mediated by Src-dependent p130
Cas phosphorylation, as
well as Src-dependent activation of Ras and extra-
cellular signal-regulated kinase (Erk)1/2. Importantly,
we demonstrate that Cav1–Rho-GTPase interaction
is crucial for a5-integrin expression. In vivo, reducing
the interaction of Cav1 with Rho-GTPases results in
decreased extravasation and reduced survival of meta-
static cells. Our data implicate the Cav1-mediated
control of Rho-GTPase signaling as an important
mechanism promoting metastasis.
Results
Cav1–Rho-GTPase interaction regulates p130
Cas
phosphorylation
Various clones of the B16 melanoma cell line exhibit
diverse metastatic potential and express different levels of
RhoC. The B16 F10 clone is the most invasive and
shows higher levels of RhoC and phosphorylated p130
Cas
(ph-p130
Cas) than the weakly invasive F0 clone (Clark
et al., 2000). We assessed the levels of Cav1 expression
in F0, F1 and F10 B16 clones, and evaluated the Src-
dependent phosphorylation of p130
Cas at Y410 and Y165.
Both Cav1 protein and ph-p130
Cas levels were increased
in F1 and F10 cells compared with F0 cells (Figure 1a). To
determine whether Cav1 was required for p130
Cas phos-
phorylation, we silenced Cav1 expression in F10 cells and
found that Cav1 indeed regulates p130
Cas phosphorylation
(Figure 1b). To deﬁne RhoC’s role in p130
Cas phosphory-
lation, we generated stable F10 clones expressing small
interfering RNA (siRNA) or short hairpin RNA against
RhoC (siRhoC, shRhoC). These cells also exhibited lower
levels of ph-p130
Cas but Cav1 expression was not altered
(Figure 1c). To determine if this effect held true in other
tumor cells, we established a cancer cell-line (designated as
PyMT) from explanted MMTV–PyMT mammary epithe-
lial tumor cells. RhoC knockdown in PyMT cells also
decreased ph-p130
Cas without affecting Cav1 (Figure 1c).
Notably, the knockdown of RhoA did not affect
ph-p130
Cas levels (Supplementary Figure S1a). These data
show that both Cav1 and RhoC regulate ph-p130
Cas in
cancer cells, and that RhoC’s function in this context
cannot be compensated for by other Rho-GTPases.
To explore whether Cav1–Rho-GTPase interaction was
important for p130
Cas phosphorylation, we exploited the
fact that the presence of the isolated CBD (Supplementary
Figures S1b and c) can inhibit Cav1–Rho-GTPase
interaction (Couet et al., 1997). We generated F10 cells
stably overexpressing the wild-type CBD (CBD
wt)o ra
non-functional mutant form of CBD (CBD
mut) (Supple-
mentary Figure S1c). We then assessed the ability of
CBD
wt to inhibit Cav1–Rho-GTPase interaction by pulling
down GTPases with GST-Rhoteckin-RBD, followed by
immunoblotting for Cav1. In CBD
wt-expressing cells, we
found that considerably less Cav1 was bound to active
Rho-GTPases in comparison with CBD
mut-expressing cells.
This indicated that the CBD
wt indeed disrupts the Cav1–
Rho-GTPase interaction (Figure 1d). To evaluate the
functional consequences of CBD
wt expression, we ex-
pressed either CBD
wt or CBD
mut in-frame with green
ﬂuorescent protein (GFP) (Supplementary Figure S1c) in
F10 cells. Cells expressing CBD
wt–GFP showed reduced
ph-p130
Cas similar to cells expressing CBD
wt alone, whereas
CBD
mut–GFP expression had no effect on ph-p130
Cas levels
(Figure 1e, Supplementary Figure S1d). Thus, the inhibi-
tion of Cav1–Rho-GTPase interaction by CBD
wt had the
same effect on ph-p130
Cas as the lack of Cav1 or RhoC
expression. These results indicate that the interaction of
Cav1 with Rho-GTPases is critical for normal p130
Cas
phosphorylation. As the lack of Cav1 or RhoC alone
almost completely abolished p130
Cas phosphorylation, we
consider RhoC as the main GTPase that binds to Cav1
and elicits p130
Cas signaling in metastatic tumor cells.
Cav1–Rho-GTPase interaction is required for cellular
migration/invasion
Activation of Rac1 is important for both migration and
cytoskeletal remodeling in many different cell types and
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Oncogenedepends on ph-p130
Cas (Klemke et al., 1998; Heasman
and Ridley 2008). We therefore assessed the effects of
CBD
wt expression or RhoC depletion on Rac1 activa-
tion, actin cytoskeleton organization and migration/
invasion in vitro. We assayed the levels of active (GTP-
bound) Rac1 in F10 cells expressing the control empty
vector (Ev), CBD
wt, CBD
mut or siRhoC, we found that
active Rac1 was dramatically reduced in F10CBD
wt and
F10siRhoC cells compared with F10CBD
mut and F10Ev
cells (Figure 2a). Consistent with the loss of Rac1
activation, rhodamine–phalloidin staining revealed that
the actin cytoskeleton of F10CBD
wt cells was clearly
altered compared with F10Ev cells (Figure 2b). The
CBD
wt-expressing cells displayed reduced F-actin stress
ﬁbers but abundant fragmented F-actin (puncta) char-
acteristic of defects in actin polymerization or stability.
This ﬁnding suggested that, in the absence of Cav1–
Rho-GTPase interaction, tumor cells might not be
able to sufﬁciently remodel their cytoskeletons to permit
migration/invasion. Indeed, F10CBD
wt and F10siRhoC
cells both exhibited severely impaired migration as well as
invasion (Figures 2c and d and Supplementary Figure S2).
These data show that cells in which Cav1–Rho-GTPase
interaction is disrupted exhibit reduced Rac1 activation
that is associated with defective cytoskeletal remodeling
and reduced migration/invasion capacity.
Cav1–Rho-GTPase interaction and RhoC are important
for Src, Ras and Erk activation
Elevated Src expression is usually associated with
increased metastatic capability (Wheeler et al., 2009).
As our earlier results showed that Cav1 controls p130
Cas
phosphorylation (Figure 1b), and Src kinase is known to
phosphorylate p130
Cas (Sakai et al., 1994), we evaluated
the impact of loss of Cav1 expression on Src activation.
F10shCav1 cells showed a signiﬁcant impairment of
SrcY416 phosphorylation compared with F10Ev cells
(Figure 3a). As RhoC depletion had a strong effect on
ph-p130
Cas levels (Figure 1c), we examined Src activation
in F10siRhoC and PyMTshRhoC cells and found that
RhoC expression was indeed crucial for Src activation
in both cell lines (Figure 3b). These data are consistent
with previous reports showing that various Rho-
GTPases are involved in recruiting Src to the plasma
membrane, and that this event may be important for Src
activation (Fincham et al., 1996; Timpson et al., 2001;
Yamana et al., 2006). Importantly, depletion of RhoC
alone was sufﬁcient to almost completely abolish Src
activation in metastatic cancer cells.
We next assessed whether CBD
wt-mediated disrup-
tion of Cav1–Rho-GTPase interaction could prevent
Src activation. F10CBD
wt cells did show a decrease in
Src activation, although to a lesser extent than in cells
lacking Cav1 or RhoC (Figure 3c). Furthermore, consis-
tent with the decreased Src activation in F10CBD
wt cells,
the levels of activated FAK and Pyk2, two direct down-
stream targets of Src, were reduced upon RhoC knock-
down or CBD
wt expression (Figure 3c). Importantly, the
expression in F10 cells of a dominant-negative form of
Src (Src-DNRF) showed the same suppressive effect on
FAK and Pyk2 phosphorylation. As FAK and Pyk2 are
involved in cell migration/invasion and adhesion (Ilic
et al., 1995; Sieg et al., 1998; Schaller 2010), the altered
Figure 1 RhoC and Cav1 regulate p130
Cas phosphorylation. (a) Correlation between Cav1 and ph-p130
Cas. The indicated clones
of B16 melanoma cells were evaluated by immunoblotting (IB) for levels of Cav1 and p130
Cas phosphorylation at Y410 or Y165.
(b) Transient silencing (two independent clones #1, #2) of Cav1 expression reduces p130
CasY410 phosphorylation. (c) RhoC controls ph-
p130
Cas levels. F10 cells stably expressing siRhoC or shRhoC were analyzed by IB to detect ph-p130
Cas and Cav1. The ph-p130
Cas levels
are also reduced in PyMT cells expressing shRhoC. (d) CBD
wt inhibits the binding of Rho-GTPases to Cav1. Active Rho-GTPases
were pulled-down with agarose beads GST-Rhoteckin-RBD-conjugated (RBD: Rho Binding Domain) and Cav1 was detected by IB.
(e) CBD
wt expression reduces ph-p130
Cas. The levels of p130
Cas and p130
Cas phosphorylated at Y410 or Y165 were assessed by IB in
F10Ev (control F10 cells expressing empty vector) and two independent clones of F10 cells overexpressing CBD
wt (F10CBD
wt #1, #2).
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Oncogeneregulation of Rac1, Src, FAK/Pyk2 that follows the
disruption of Cav1–Rho-GTPase interaction or the
reduction of RhoC expression explains the defects in
migration/invasion observed in vitro.
Erk1/2 activation downstream of Src promotes cancer
cell migration/invasion (Krueger et al.,2 0 0 1 ) .T od e t e r -
mine whether RhoC depletion or CBD
wt expression affec-
ted Erk1/2 activation, we assayed phospho-Erk1/2 levels
in F10 CBD
wt and F10siRhoC cells. Erk1/2 activation
was drastically reduced in the absence of RhoC or in
the presence of the CBD
wt, to an even greater extent
than in F10SrcDNRF cells (Figure 3d). Src acts through
Ras to elicit Erk1/2 activation (Gardner et al., 1993),
and a large body of evidence indicates that Ras is
intimately associated with integrin function required
for cell adhesion, migration and growth (Zhang et al.,
1996; Kinbara et al., 2003). Therefore, we ﬁrst assayed
Ras activation in F10CBD
wt and F10shRhoC cells
and found that disruption of Cav1–Rho-GTPase inter-
action, or RhoC silencing, markedly reduced the levels
of Ras-GTP (Figure 3e). Next, we examined a5-integrin
expression in F10CBD
wt, F10CBD
mut, F10shRhoC and
F10shRhoA. We found that control F10 cells expressed
high levels of a5-integrin, a marker that correlates with a
highly malignant phenotype in melanoma (Natali et al.,
1995; Keely et al., 1998). We detected similar levels
of a5-integrin in F10CBD
mut cells but found a drastic
reduction of a5-integrin expression in CBD
wt-expressing
cells and in shRhoC cells (Figure 3f). Remarkably,
F10shRhoA cells showed only a slight reduction on a5-
integrin expression. The a6-integrin and b1-integrin
expression was not affected (data not shown). To further
characterize the a5-integrin expression, we assessed
the effects of the expression of CBD
wt, shRhoC and
shRhoA on a5-integrin mRNA levels. We found that
only the CBD
wt or shRhoC expression profoundly
reduced the mRNA levels of a5-integrin (Figure 3g).
Notably, the expression of CBD
wt had no negative
impact on RhoC expression. The reduced expression
of a5-integrin in cells expressing CBD
wt or shRhoC is
consistent with their inability to metastasize.
Taken together, our results suggest that Cav1–Rho-
GTPase interaction is important not only for Src,
Ras and Erk1/2 activation but also for a5-integrin
expression required for cancer cell migration/invasion.
As the reduction of RhoC has a major impact on these
molecules, we believe that RhoC is the main GTPase
contributing to the migratory and invasive properties of
melanoma cells.
Disruption of Cav1–Rho-GTPase interaction reduces
metastasis in mice
Erk1/2 have roles in cell motility but these molecules are
also crucial for cancer cell proliferation and survival
(Dent et al., 1999; Shaul and Seger 2007; Mebratu and
Figure 2 Effects of disrupting the Cav1–Rho-GTPase interaction. (a) Decreased Rac1 activation in the presence of CBD
wt or absence
of RhoC. Active Rac1 (Rac1-GTP) was pulled down with GST-PAK-PDB-conjugated agarose beads (PAK: p21-activated kinase 1;
PDB: p21-binding domain) from extracts of F10 cells expressing Ev, CBD
mut, CBD
wt, siRhoC. Rac1 was detected by IB. (b) CDB
wt
expression alters cytoskeletal remodeling. Rhodamine–phalloidin stainings of F10CBD
wt cells show abundant F-actin fragments and
reduced F-actin stress ﬁbers compared with F10Ev cells. Insets, 2.5-fold magniﬁcation of a representative cell area. (c, d) CBD
wt
expression impairs migration/invasion. Top: F10Ev cells are able to migrate on collagen IV-coated ﬁlters; F10CBD
wt cells are unable to
do so. Bottom: F10CBD
wt cells show severe impairment to invade Matrigel. Quantiﬁcation was performed by using ImagePro software
(Media Cybernetics, Inc., Bethesda, MD, USA)—‘ﬁlter-area’ occupied by cells is presented in percentage of migration/invasion,
***¼statistically signiﬁcant (two-tailed t-test with s.e.m.), Po0.001.
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OncogeneTesfaigzi 2009). As CBD
wt expression reduced Erk1/2
activation (Figure 3d), we assessed whether CBD
wt
expression could alter the metastatic potential of cancer
cells in vivo. Luciferase-expressing F10Ev, F10CBD
wt
and F10CBD
mut cell lines were tail-vein injected into
C57/B6 mice, and monitored for metastasis and
survival. Non-transfected F10 cells and F10Ev cells
had metastasized by 2 weeks post-injection (Figure 4a,
top). Similarly, mice injected with F10CBD
mut cells also
showed extensive metastasis (Figure 4a, middle). How-
ever, mice injected with F10CBD
wt cells did not develop
lung tumors until 3 weeks post-injection, and no signi-
ﬁcant spread of cancer cells was observed until 4 weeks
post-injection (Figure 4a, bottom). As a consequence,
mice injected with F10CBD
wt cells had a lifespan that
was double that of mice injected with either F10Ev or
F10CBD
mut cells (Figure 4b). Comparable results were
obtained when these studies were repeated using female
mice (Supplementary Figure S3). In line with our earlier
results (Figures 3c and d), SrcDNRF expression also
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Oncogenegreatly diminished the aggressiveness of the injected
F10 cells and prolonged mouse lifespan (Figure 4c).
Similar results were obtained when luciferase-expressing
PyMT-CBD
wt or PyMT-Ev cells were injected into the
tail veins of SCID mice. Whereas PyMT-Ev cells readily
established tumors in the lungs, PyMT-CBD
wt cells
failed to do so (Figure 5a). As a consequence, mice that
received PyMT-CBD
wt cells lived much longer than
animals injected with PyMT-Ev cells (Figure 5b). PyMT
cells expressing SrcDNRF were also less metastatic
Figure 4 Disruption of the Cav1–Rho-GTPase interaction in F10 cells: in vivo effects. (a) CBD
wt expression reduces metastasis. Top
panel, controls. Male C57/B6 mice were grafted with: PBS containing no cells (left), F10Ev cells (middle) or naive F10 cells (right).
Middle and bottom panels, male mice were tail-vein injected with F10CBD
mut or F10CBD
wt cells, respectively. Mice were imaged at the
indicated time points post-injection using a Xenogen apparatus (Caliper Life Sciences (Corporate Headquarters), Hopkinton, MA,
USA). (b) Extended lifespan of mice tail-vein injected with F10CBD
wt cells. The survival of the indicated mice from (a) was examined
using Kaplan Meier plots. Median overall survival: F10Ev, 21.75 days (n¼6 mice); F10CBD
mut, 22.6 days (n¼10 mice); F10CBD
wt,
51.4 days (n¼10 mice). Log-rank test: F10Ev vs F10CBD
wt, Po0.001; F10CBD
mut vs F10CBD
wt, Po0.001; F10Ev vs F10CBD
mut,
P¼0.106. (c) Kaplan–Meier survival plots for C57/B6 mice tail-vein injected with F10Ev or F10SrcDNRF cells. Median overall
survival: F10Ev, 21.75 days (n¼10 mice); F10SrcDNRF, 62.2 days (n¼10 mice). Log-rank test, Po0.001.
Figure 3 Cav1–Rho-GTPase interaction or RhoC regulate Ras/Erk1/2 and FAK/Pyk2 activation through Src. (a) Cav1 controls Src
activity. Src activation (Src phosphorylated at Y416) is severely impaired upon loss of Cav1 expression while the total level of Src is not
affected. (b) RhoC is involved in Src activation. Src activation was assessed by IB in extracts of F10 and PyMT cells stably expressing
siRhoC or shRhoC. (c) Cav1–Rho-GTPase interaction or RhoC control Src, FAK and Pyk2 activation. Phosphorylated tyrosins of
Src, FAK and Pyk2 were detected by IB in extracts of two independent F10 clones stably expressing the CBD
wt and clones of F10 cells
stably expressing shRhoC, siRhoC or Src-DNRF. The expression of the CBD
wt, the RhoC silencing or the expression of a Src
dominant-negative form have all the effect of reducing the activation of Src, FAK and Pyk2. (d) Cav1–Rho-GTPase interaction or
RhoC control Erk1/2 activation. Activated Erk1/2 were detected by IB in extracts of two independent clones of F10 cells stably
expressing the CBD
wt and clones of F10 cells stably expressing shRhoC, siRhoC or Src-DNRF. The expression of the CBD
wt, RhoC
silencing or the expression of Src-DNRF reduce the activation of Erk1/2. (e) Cav1–Rho-GTPase interaction or RhoC control Ras
activation. Active Ras (Ras-GTP) was pulled down with agarose beads GST-RBD-conjugated (RBD: Raf 1-binding domain) from
extracts of F10 cells stably expressing the CBD
wt, the CBD
mut or shRhoC. Ras was detected by IB. Either the expression of the CBD
wt
or RhoC silencing impairs Ras activation when compared with the expression of the CBD
mut.( f) Fluorescence-activated cell sorting
analysis of a5-integrin expression. The graphs are representative of three independent experiments. The expression of a5-integrin of
F10 cells expressing the CBD
wt or shRhoC is drastically reduced in comparison with cells expressing the CBD
mut. The silencing of
RhoA has a minimal effect on a5-integrin expression. (g) Cav1–Rho-GTPase interaction or RhoC control a5-integrin expression. The
mRNA expression levels of RhoA, RhoC and a5-integrin were assessed by quantitative reverse transcriptase–PCR. The expression of
the CBD
wt decreases a5-integrin mRNA level without affecting RhoC expression. RhoC silencing also decreases a5-integrin mRNA
level. RhoA silencing has a minimal effect on a5-integrin mRNA level, ***¼statistically signiﬁcant (two-tailed t-test with s.e.m.),
Po0.001.
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Oncogenethan controls, as judged by mouse survival (Figure 5c).
Remarkably, the injection of RhoC null PyMT cells
(PyMT-RhoC
 /  cells; Hakem et al., 2005) did not show
detectable metastasis or caused the death of any experi-
mental animal (Figure 5d and data not shown). These
in vivo results suggest that disruption of Cav1–Rho-
GTPase interaction, and/or the inhibition of Src, Ras
and Erk1/2 activation that stems from it, can reduce the
metastatic potential of cancer cells.
Disruption of Cav–Rho-GTPase interaction impairs
cancer cell extravasation and survival in vivo
The reduced metastasis of CBD
wt-expressing cells could
be due to either a decreased capacity of these cells to
extravasate or a compromised ability to engraft and
survive in a secondary site. To distinguish between these
possibilities in vivo, we examined the behavior of F10
cells injected into chicken embryos. We generated
F10CBD
wt cells expressing GFP (F10CBD
wtGFP cells),
and control F10 cells expressing Ev and the ﬂuorescent
protein tomato (F10Ev-tomato cells). The engraftment
capacity of these cells was then assessed by injecting
them into a vein in the chorioallantoic membrane of the
chicken embryo. Quantitative alu PCR was used to
determine the number of mouse tumor cells migrating to
the lungs and liver (Zijlstra et al., 2002, 2008). At 5 days
post-injection, the metastatic load in the lung (Figures
6a and b) and liver (Figures 6c and d) attributable to
F10CBD
wtGFP cells was about fourfold lower than the
metastatic load associated with F10Ev-tomato cells.
Thus, cells lacking Cav1–Rho-GTPase interaction have
Figure 5 Disruption of the Cav1–Rho-GTPase interaction in PyMT tumor cells: in vivo effects. (a) Less metastasis by CBD
wt
expression. SCID mice were tail-vein injected with PBS alone (top panel), PyMT-Ev cells (middle panel) or PyMT-CBD
wt cells (bottom
panel). Mice were imaged at 2 weeks post-injection using Xenogen. (b, c) Increased survival of mice bearing tumor cells expressing
CBD
wt or SrcDNRF. Kaplan–Meier survival plots for SCID mice tail-vein injected with PyMT-Ev, PyMT-CBD
wt or PyMT-SrcDNRF
cells. Median overall survival: PyMT-Ev, 47 days (n¼6 mice); PyMT-CBD
wt, not reached at 84 days (n¼6 mice). Log-rank test,
P¼0.021. PyMT-SrcDNRF, 76 days (n¼6 mice). Log-rank test, Po0.001. (d) Kaplan–Meier survival plots for 129P2 mice tail-
injected with PyMT-wt or PyMT-RhoC
 /  cells. Median overall survival: PyMT-wt, 65 days (n¼5 mice), PyMT-RhoC
 /  not reached.
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in chicken embryos.
Next, we used intravital imaging to compare the
extravasation of F10CBD
wtGFP and F10Ev-tomato
cells. This technique allows the visualization of tumor
cells within blood vessels (Lewis et al., 2006), as they are
extravasating, and after they have successfully extra-
vasated into the surrounding stroma. Although the
extravasation rate of F10CBD
wtGFP cells was similar
to that of F10Ev-tomato cells (Figure 7a), the attrition
rate of F10CBD
wtGFP cells during extravasation was
double that of F10Ev-tomato cells (Figure 7b). Conse-
quently, fewer F10CBD
wtGFP cells than F10Ev-tomato
cells successfully completed extravasation (Supplemen-
tary Movies 1, 2). This decrease in the viability of
F10CBD
wtGFP cells coincided with morphological
alterations not seen in F10Ev-tomato cells, either during
or after extravasation. Speciﬁcally, F10CBD
wtGFP-
expressing cells showed a greater number of branched
protrusions (Supplementary Figure S4) that may have
affected the ability of these cells to extravasate. These
data imply that the reduced metastasis that follows
CBD
wt expression may be due in part to detrimental
effects on tumor cell survival during extravasation and
in the secondary site.
Discussion
Cav1 and Rho-GTPases have important roles in cell
movement, growth, survival, cancer progression and
metastasis. Cav1 orchestrates various signaling mole-
cules among Rho-GTPases, which bear a CBD and
interact directly with Cav1. Cav1 regulates cell polariza-
tion and directional migration through a process
involving Src and Rho-GTPases (Grande-Garcia et al.,
2007). RhoC contains a putative CBD and interacts
directly with Cav1 (Lin et al., 2005). Therefore, the
Cav1–Rho-GTPase interaction should be of important
biological signiﬁcance.
We have provided evidence that the expression of the
CBD
wt does not affects RhoC expression but disrupts
the Cav1–Rho-GTPase interaction and compromises
cell migration/invasion and survival by altering the
expression of a5-integrin, the activity of Src and down-
stream activation of p130
Cas/Rac1, FAK/Pyk2 and Ras/
Erk1/2. The expression of a5-integrin is virtually
absent in CBD
wt-expressing cells or in cells lacking
RhoC but it is only marginally affected by RhoA
silencing. This argues that the absence of a5-integrin is
due to the disrupted interaction of Cav1 and RhoC. At
the biochemical level, the expression of the CBD
wt or the
Figure 6 Disruption of the Cav1–Rho-GTPase interaction reduces metastasis in chicken embryos. F10Ev-tomato and F10CBD
wtGFP
cells were injected intravenously into the chorioallantoic membrane of chicken embryos and the metastatic spread of these cells to the
lungs (a, b) and liver (c, d) was assessed at 24h and 5 days post-injection. (a, c) Imaging of dissected lungs and liver of chicken embryos
injected with F10Ev-tomato (top) or F10CBD
wtGFP cells (bottom), showing brightﬁeld, ﬂuorescence and overlay images at 5 days
post-injection. (b, d) Quantitation of metastases in lungs (b) and liver (d) at 24h and 5 days post-injection was performed using
quantitative alu PCR, ***¼statistically signiﬁcant (two-tailed t-test with s.e.m.), Po0.001.
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wt-
expressing cells and cells lacking RhoC exhibit a drastic
reduction of Src activity. The reduction of Src activation
has several effects. First, Src-dependent p130
Cas phos-
phorylation is reduced causing the consequent drastic
decrement of Rac1 activation. Rac1 has been shown to
be a crucial mediator of Src-dependent actin cytoskele-
ton organization and cell migration (Timpson et al.,
2001; Bosco et al., 2009). The observed changes on
p130
Cas/Rac1 activation and altered actin cytoskeleton
by CBD
wt-expressing cells do explain the migration/
invasion defects observed in vitro. Also, Src-dependent
activation of FAK and Pyk2 is affected by CBD
wt
expression or lack of RhoC. In addition to their
known involvement in cell adhesion (Schaller 2010),
FAK and Pyk2 have been shown to support cell
proliferation in a p53-dependent manner (Lim et al.,
2008, 2010). Therefore, CBD
wt-expressing and RhoC
knockdown cells lack survival signals provided by either
FAK or Pyk2.
The activation of Ras and Erk1/2 is also impaired in
both CBD
wt-expressing cells and cells lacking RhoC.
This is consistent with the notion that the Src kinase
family can affect cell proliferation via the Ras/ERK/
mitogen-activated protein kinase pathway (Minden
et al., 1995; Kim et al., 2009). Moreover, Ras and
Erk1/2 have been shown to be involved in cell
migration, proliferation and survival (Giehl 2005; Torii
et al., 2006). We show for the ﬁrst time that Ras and
Erk1/2 activation as well as a5-integrin expression might
be entirely dependent on RhoC signaling in B16
melanoma cells. Mechanistically, RhoC signaling might
affect a5-integrin expression ﬁrst and that this event,
in turn, activates the Src/p130
Cas/Rac1 signaling cascade.
Rho-GTPases are important for integrin clustering/
function (Keely et al., 1998), because the prevention
Figure 7 CBD
wt expression interferes with extravasation and cell survival in vivo. F10Ev-tomato and F10CBD
wtGFP cells were
injected intravenously into the chorioallantoic membrane of a chicken embryo and monitored using 3D intravital ﬂuorescence imaging.
(a) Imaging. The status of each tumor cell relative to the vasculature was visualized, whether intravascular (left), in the process
of extravasating (middle), or extravasated (right). Both F10Ev-tomato and F10CBD
wtGFP cells were able to extravasate in the CAM.
(b) CBD
wt expression decreases extravasation of tumor cells and profoundly reduces tumor cell survival. The extravasation of
individual tumor cells (F10Ev-tomato, n¼1375 cells; F10CBD
wtGFP, n¼1365 cells) was monitored over 18h. After 1h, all cells were
intravascular. After 8h, 44.9% more F10Ev-tomato cells had extravasated than F10CBD
wtGFP cells (P¼0.016). After 18h, 54.2%
more F10Ev-tomato cells had extravasated than F10CBD
wtGFP cells (P¼0.0007), ***¼statistically signiﬁcant (two-tailed t-test with
s.e.m.), Po0.001. This difference in extravasation rate coincides with higher cell death (missing/dead) of F10CBD
wtGFP cells.
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decreases a5-integrin mRNA and protein expression
(Kidera et al., 2010). On the other hand, Ras can
activate integrin signaling although integrin expression
is not controlled directly by Ras (Kinbara et al.,
2003). The importance of a5-integrin in cell survival/
apoptosis becomes evident when considering that high
a5-integrin expression is detrimental for breast cancer
patients (Nam et al., 2010). Moreover, various other
cancer cell types depend on a5-integrin expression/
function for their survival (O’Brien et al., 1996; Qian
et al., 2005; Haenssen et al., 2010). Besides, block of
a5-integrin expression/function has been shown to
decrease the invasiveness and adhesiveness of cancer
cells (Mierke et al., 2011).
We demonstrate that mice or chicken embryos injec-
ted with CBD
wt-expressing melanoma cells show great
reduction of metastatic burden. The effects of the
CBD
wt-expression were not limited to melanoma cells
because PyMT mammary gland tumor cells were
similarly affected in vivo. Intravital microscopy revealed
that CBD
wt-expressing cells encounter problems during
extravasation and also display markedly reduced ability
to survive post extravasation. We provide the ﬁrst
evidence that the Cav1–Rho-GTPase interaction is
important for melanoma cells to extravasate and survive
in vivo.
In conclusion, the disruption of the Cav1–Rho-
GTPase interaction and the absence of RhoC have
the same biochemical/phenotypic effects, therefore we
speculate that RhoC is responsible for the metastatic
properties of B16 melanoma cells. We suggest that
Cav1–RhoC interaction and downstream signaling
controls a5-integrin expression. Subsequently, a5-integ-
rin signaling activates the Src/FAK/p130
Cas pathway
(Wu et al., 2008) that leads to Rac1 and Ras/Erk1/2
activation, which altogether is crucial for the migration/
invasion and survival of metastatic melanoma cells.
Materials and methods
Additional details of material and methods can be found in
Supplementary Information.
Plasmids
Plasmids containing the wild-type and mutant forms of
CBD were created by ligating synthetic duplex oligonucleo-
tides into the BamHI/EcoRI sites of pcDNA3.1. The G418- or
hygromycin-resistant versions of pcDNA3.1 were used for all
cloning. SrcDNRF construct (Millipore, Billerica, MA, USA;
Cat#21–154).
Cancer cell lines and transfections
B16 F0, F1 and F10 melanoma cells were purchased from
American Type Culture Collection (ATCC, Manassas, VA,
USA) and maintained in Iscove’s modiﬁed Dulbecco’s media
containing 10% fetal bovine serum. B16 F10 cells expressing
luciferase were purchased from Caliper LifeSciences (Corpo-
rate Headquarters), Hopkinton, MA, USA). PyMT primary
mammary tumor cells were derived in-house from
MMTV–PyMT mice. Mammary tumor cells were cultured in
Dulbecco’s modiﬁed Eagle’s medium/HAM-F12 (1:1) media
containing 10% fetal bovine serum, 0.5mg/ml hydrocortisone
(Sigma-Aldrich, St Louis, MO, USA), 5mg/ml insulin (US
Biological, Marblehead, MA, USA) and 5ng/ml epidermal
growth factor (US Biological) under standard conditions
(371C, 5% CO2) until spontaneous immortalization occurred.
Tumor cells were transfected with plasmids using a standard
lipofectamine transfection procedure (Invitrogen Canada,
Burlington, ON, Canada) and the desired clones were isolated
by selection in the appropriate agents/antibiotics.
RNA interference-mediated gene silencing
For transient silencing, cells were transfected with 200 pmoles
siRNA (either control scrambled siRNA or siRNA against
RhoC from Ambion, Applied Biosystems, Carlsbad, CA,
USA) using Lipofectamine2000 (Invitrogen) according to the
manufacturer’s protocol. siRNA sequences are listed in
Supplementary Information. Transfected cells were analyzed
by immunoblotting at 72h post-transfection as described
below. For stable knockdowns, control siRNA and short
hairpin RNA against RhoC, Cav1, RhoA were either cloned
into the pSilencer vector (Ambion) or were purchased ready
for lentiviral expression (Open Biosystems Products, Hunts-
ville, AL, USA; Sigma-Aldrich). Lentiviral particles were
produced in 293FT cells and virus-containing culture super-
natants were used to infect cells in the presence of 8mg/ml
polybrene (Sigma).
Immunoblotting
Extracts of transfected or transduced cells were prepared in
RIPA buffer. Equal amounts of protein were resolved by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis and
subjected to immunoblotting using the following antibodies:
rabbit polyclonal anti-Cav1 (Santa-Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA); rabbit polyclonal anti-p130
Cas (Sigma);
rabbit polyclonal antibodies speciﬁc for the Y165 or Y410
phosphorylated forms of p130
Cas, or phosphorylated Src-Y416
(Cell Signaling Technology, Inc., Danvers, MA, USA), rabbit
polyclonal antibodies speciﬁc for FAK-Y925, Pyk2-Y402,
total Erk1/2; or phosphorylated forms of Erk1/2-T202/Y204
(Cell Signaling). To detect Cav1 bound to Rho-GTPases in the
presence of the CBD
wt and CBD
mut, immunoblotting of
immunoprecipitates obtained using the Rho activation kit
(Millipore) was performed using anti-Cav1 antibody as above.
Anti-Rho (-A, -B, -C) antibody, clone 55 (Millipore), anti-
Rac1 mouse monoclonal antibody (Cytoskeleton Inc., Denver,
CO, USA) and anti-Ras monoclonal antibody clone RAS10
(Millipore).
Transwell migration/invasion and wound-healing assays
For Transwell migration/invasion, cells (1 10
5) that had
been cultured overnight in media containing 0.2%. Fetal
bovine serum was plated into the upper chamber of a
Transwell insert (8mm pore size) that had been coated with
collagen-IV for migration assays, or with Matrigel for invasion
assays (BD - Canada, Mississauga, ON, Canada). The upper
and lower chambers were then ﬁlled with medium containing
5% fetal bovine serum and the cells were cultured for 24h
under standard conditions. For visualization, cells were ﬁxed
and stained with 1% methylene blue in 50% methanol. For the
wound-healing assay, cell cultures at near-conﬂuence were
wounded by creating a ‘scratch’ in the cell monolayer. At 48h
post-wounding, cell migration was examined after cell cultures
were ﬁxed by staining with 1% methylene blue in 50%
methanol.
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Cells (5 10
6) were serum-starved overnight before stimulation
for 15min with 50ng/ml insulin-like growth factor (IGF; US
Biologicals) for Rho-GTPase and Ras activation, or for 5min
with 10ng/ml insulin-like growth factor for Rac1 activation.
Speciﬁc activation of GTP-loaded Rho-GTPases, Rac1 or Ras
was detected using the Rho activation kit (Millipore), the Rac1
activation kit (Cytoskeleton Inc.) or the Ras activation kit
(Millipore), respectively, according to each manufacturer’s
protocol.
Actin visualization
Cells (2 10
4) were plated on uncoated 12mm glass coverslips
and allowed to attach overnight before ﬁxation in 2%
formaldehyde/phosphate-buffered saline (PBS) and permeabi-
lization in 0.5% Triton-X-100/PBS. Permeabilized cells were
washed in PBS and actin was detected by rhodamine–
phalloidin (PHDR1; Cytoskeleton Inc.). Fluorescent images
were obtained using an Olympus-Fluoview-FV1000 confocal
microscope (Olympus Canada Inc., Markham, ON, Canada).
Integrin assays and quantitative reverse transcriptase–PCR
The expression of a5-integrin was assessed by ﬂuorescence-
activated cell sorting analysis on a BD FACSCanto II
ﬂow cytometer. Cells (10
6) were stained with anti-CD49e
(a5-integrin) antibody BD clone 5H10-27.
The mRNA level was assessed by quantitative reverse
transcriptase–PCR. TRIzol reagent (Invitrogen) was used
for RNA extraction and the iScript reverse transcription-kit
(Bio-Rad Laboratories (Canada) Ltd., Mississauga, ON,
Canada) to produce complementary DNA. The quantitative
reverse transcriptase–PCR reaction was performed using
SYBR Green (Applied Biosystems, Carlsbad, CA, USA) and
the Applied Biosystems Real-time PCR-7900HT. The gapdh
gene ampliﬁcation was used as internal reference.
In vivo analyses of metastasis in mice
Tumor cells (5 10
5 in 100ml PBS) were injected into the
tail-vein of C57/B6 or SCID mice. In situ imaging of luciferase-
expressing metastatic cells was performed using a Xenogen
apparatus (IVIS Imaging Systems, Caliper LifeSciences).
Mouse survival over 60–80 days was evaluated using
Kaplan–Meier methodology. All animal experiments were
approved by the Animal Care and Use Committee of the
University Health Network (Toronto, Canada).
Quantitation of in vivo metastasis in chicken embryos
Fertilized chicken eggs were incubated in a rotary incubator
at 371C with 70% humidity for 4 days before being removed
from the shell and placed in covered dishes. On day 12 of
development, 2 10
5 tumor cells in 50ml PBS were injected
into a vein within the chorioallantoic membrane. Chicken
embryonic liver and lung were harvested at 24h and 5 days
post-injection and mouse tumor cells in these organs were
measured using quantitative PCR to detect the mouse alu
sequence. The cT values obtained from the mouse alu ampli-
ﬁcation were normalized to the chicken GAPDH as previously
described (Zijlstra et al., 2002, 2008).
Intravital imaging of tumor cell migration and extravasation
Real-time imaging of the intravascular migration and extra-
vasation of mouse tumor cells in chicken embryos was
performed using a chicken embryo imaging unit as previously
described (Zijlstra et al., 2008). Brieﬂy, the embryonic chicken
vasculature was labeled with ﬂuorescent Lens Culinaris
Agglutinin (LCA, Vector Laboratories, Burlingame, CA,
USA). F10CBD
wtGFP or F10Ev-tomato cells (2 10
5) were
injected into a vein within the chorioallantoic membraneand
the embryos were visualized using a spinning-disk confocal
microscope (Quorum Technologies, Waterloo, ON, Canada).
Statistics
Kaplan–Meier survival plots and intergroup comparison
statistics were determined by using GraphPad PRISM-5
software (GraphPad Software, Inc., La Jolla, CA, USA).
The log-rank test was used to evaluate differences in animal
survival among experimental groups (P-value). The two-tailed
t-test with s.e.m. was used to evaluate differences in tumor cell
extravasation and survival in chicken embryos.
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